Approval · Notice of Compliance 18504 · 2016
DRAXXIN: Notice of Compliance 18504
Issued September 23, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18504
- Date
- September 23, 2016
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Modification to the indication and warnings statement
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DRAXXIN | 02285452 | Marketed |
Medicinal ingredients
- TULATHROMYCIN 100 MG per ML